DOP2013000309A - PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN - Google Patents

PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN

Info

Publication number
DOP2013000309A
DOP2013000309A DO2013000309A DO2013000309A DOP2013000309A DO P2013000309 A DOP2013000309 A DO P2013000309A DO 2013000309 A DO2013000309 A DO 2013000309A DO 2013000309 A DO2013000309 A DO 2013000309A DO P2013000309 A DOP2013000309 A DO P2013000309A
Authority
DO
Dominican Republic
Prior art keywords
pharmaceutical composition
inflammation
pain
combination
composition
Prior art date
Application number
DO2013000309A
Other languages
Spanish (es)
Inventor
Juan Pablo Senosiain Peláez
María Angélica Arzola Paniagua
Enrique Raul García Salgado López
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of DOP2013000309A publication Critical patent/DOP2013000309A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una combinación y composición farmacéutica y particularmente a una combinación de un analgésico y un antiinflamatorio seleccionado de ketorolaco y meloxicam o piroxicam, y vehículos o excipientes farmacéuticamente aceptables. También se refiere a un proceso de fabricación de una composición farmacéutica y al uso de dicha composición para elaborar un medicamento útil para tratar los padecimientos de dolor e inflamación.The present invention relates to a combination and pharmaceutical composition and particularly to a combination of an analgesic and an anti-inflammatory selected from ketorolac and meloxicam or piroxicam, and pharmaceutically acceptable carriers or excipients. It also refers to a manufacturing process of a pharmaceutical composition and the use of said composition to make a useful medicine to treat pain and inflammation.

DO2013000309A 2011-06-22 2013-12-20 PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN DOP2013000309A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011006758A MX357376B (en) 2011-06-22 2011-06-22 Pharmaceutical composition for use against inflammation and pain.

Publications (1)

Publication Number Publication Date
DOP2013000309A true DOP2013000309A (en) 2014-04-15

Family

ID=47422093

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2013000309A DOP2013000309A (en) 2011-06-22 2013-12-20 PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN

Country Status (13)

Country Link
AR (1) AR086733A1 (en)
BR (1) BR112013033007A2 (en)
CL (1) CL2013003671A1 (en)
CO (1) CO6831987A2 (en)
CR (1) CR20130687A (en)
DO (1) DOP2013000309A (en)
ES (1) ES2441917B1 (en)
GT (1) GT201300318A (en)
MX (1) MX357376B (en)
NI (1) NI201300142A (en)
PE (1) PE20141530A1 (en)
RU (1) RU2604149C2 (en)
WO (1) WO2012176155A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2586607B1 (en) * 2013-05-27 2017-07-20 Farmacéuticos Rayere, S.A. SYNERGISTIC PHARMACEUTICAL COMPOSITION OF TWO ANALGESICS WITH DIFFERENT PHARMACOCINETIC PROFILE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (en) * 1984-10-22 1988-11-16 Chiesi Farma Spa AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
MXPA02010828A (en) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain.
RU2237470C1 (en) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Combined preparation for removing symptoms of catarrhal diseases and grippe (variants)
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
MXPA04009698A (en) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Solid pharmaceutical formulations comprising diacereine and meloxicam.
WO2007148950A1 (en) * 2006-06-20 2007-12-27 Farmacéuticos Rayere, S.A. Synergistic pharmaceutical composition of ketorolac and lysine clonixinate
MX2007003948A (en) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management.
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
CR20130687A (en) 2014-02-21
CL2013003671A1 (en) 2014-07-11
RU2013157013A (en) 2015-07-27
CO6831987A2 (en) 2014-01-10
MX2011006758A (en) 2013-01-10
MX357376B (en) 2018-07-06
BR112013033007A2 (en) 2017-01-31
AR086733A1 (en) 2014-01-15
RU2604149C2 (en) 2016-12-10
ES2441917R1 (en) 2014-02-19
ES2441917B1 (en) 2014-11-25
NI201300142A (en) 2015-02-25
PE20141530A1 (en) 2014-11-12
WO2012176155A1 (en) 2012-12-27
ES2441917A2 (en) 2014-02-06
GT201300318A (en) 2015-05-21

Similar Documents

Publication Publication Date Title
SV2015005115A (en) DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES
EA201591751A1 (en) TRIPEPTIDE EPOKEKETONE PROTEASE INHIBITORS
CL2015001891A1 (en) Enclosed controlled dose dosage forms resistant to tampering; use to treat pain; and method of preparation. (divisional of the application n ° 2754-2014).
CL2013000481A1 (en) Method and to improve the efficacy and / or reduce the side effects of a suboptimally administered pharmacotherapy comprising the administration of a substituted hexitol; pharmaceutical composition; pharmaceutical combination; Use to treat proliferative diseases.
CL2013000063A1 (en) A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
AR091876A1 (en) PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
BR112015009228A8 (en) STERILE LIQUID PHARMACEUTICAL FORMULATION AND STERILE LIQUID OPHTHALMIC INTRAOCULAR DOSAGE FOR INJECTION
CL2011002858A1 (en) Use of an oral transmucosal pharmaceutical composition comprising dexmedetomidine and a pharmaceutically acceptable salt and a pharmaceutically acceptable excipient to prepare a medicament useful for treating or preventing pain.
EA201170940A1 (en) CANCER TREATMENT USING BENDAMUSTIN AND ANTI-CD20-ANTIBODY COMBINATION
UY33277A (en) SPIRO-TETRACICLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
JO3326B1 (en) Tripeptide Epoxy Ketone Protease Inhibitors
EA201491039A1 (en) COMBINATION DIACEREIN AND NONSTEROIDAL ANTI-INFLAMMATORY MEDICINES
CY1123695T1 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY AGENTS AND PROCESS OF PREPARATION
SV2010003773A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME
EA201591603A1 (en) NEW THERAPEUTIC COMBINATIONS MYRTAZAPINE FOR APPLICATION IN PAIN DISEASES
CR20130687A (en) PHARMACEUTICAL COMPOSITION FOR USE IN INFLAMMATION AND PAIN
ECSP088801A (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A KETOROLACO SALT AND VITAMINS OF COMPLEX B FOR THE TREATMENT OF NEURALGIA
CL2016002655A1 (en) Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride
EA201290378A1 (en) COMPOSITIONS CONTAINING NESTEROIDIC ANTI-INFLAMMATORY MEDICINES
ES2422877B1 (en) COMBINATION AND COMPOSITION FOR OBESITY TREATMENT
ECSP13012765A (en) COMBINATION AND COMPOSITION FOR OBESITY TREATMENT
CO7170180A2 (en) Injectable pharmaceutical composition of dexketoprofen and tramadol
EA201200799A1 (en) HEPATATROPETECTED MEDICINE
CL2011002933A1 (en) Compounds derived from pharmaceutically acceptable salts of immetridine, h3 agonist; pharmaceutical composition comprising them; compound preparation procedure; pharmaceutical combination; and its use in the treatment of CNS diseases.